D-0520-2016 Class III Terminated
FDA drug recall D-0520-2016 was initiated by Pfizer Inc. on Dec 2, 2015 and is designated Class III. Reason for recall: Failed Dissolution Specification The recall status is terminated (terminated Jul 26, 2017). Affected quantity: a) 4005 bottles, b) 104 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 16, 2015
- Initiation Date
- Dec 2, 2015
- Termination Date
- Jul 26, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 4005 bottles, b) 104 bottles
Product description
Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.
Reason for recall
Failed Dissolution Specification
Distribution pattern
Nationwide
Code information
Lot #: C150065; C150064, Exp 6/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0520-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026